CVS Health Corporation
CVS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $372,809 | $357,776 | $322,467 | $292,111 |
| % Growth | 4.2% | 10.9% | 10.4% | – |
| Cost of Goods Sold | $321,408 | $303,345 | $267,965 | $239,991 |
| Gross Profit | $51,401 | $54,431 | $54,502 | $52,120 |
| % Margin | 13.8% | 15.2% | 16.9% | 17.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $40,240 | $0 | $0 | $0 |
| SG&A Expenses | $41,229 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $989 | $0 | $0 | $0 |
| Other Operating Expenses | $1,656 | $40,688 | $46,548 | $38,810 |
| Operating Expenses | $42,885 | $40,688 | $46,548 | $38,810 |
| Operating Income | $8,516 | $13,743 | $7,954 | $13,310 |
| % Margin | 2.3% | 3.8% | 2.5% | 4.6% |
| Other Income/Exp. Net | -$2,368 | -$2,570 | -$2,118 | -$2,773 |
| Pre-Tax Income | $6,148 | $11,173 | $5,836 | $10,537 |
| Tax Expense | $1,562 | $2,805 | $1,509 | $2,548 |
| Net Income | $4,614 | $8,344 | $4,311 | $8,001 |
| % Margin | 1.2% | 2.3% | 1.3% | 2.7% |
| EPS | 3.66 | 6.49 | 3.29 | 6 |
| % Growth | -43.6% | 97.3% | -45.2% | – |
| EPS Diluted | 3.66 | 6.47 | 3.26 | 5.95 |
| Weighted Avg Shares Out | 1,259 | 1,285 | 1,312 | 1,319 |
| Weighted Avg Shares Out Dil | 1,262 | 1,290 | 1,323 | 1,329 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2,958 | $2,658 | $2,287 | $2,503 |
| Depreciation & Amortization | $4,597 | $4,366 | $4,224 | $4,486 |
| EBITDA | $13,683 | $18,197 | $12,347 | $17,526 |
| % Margin | 3.7% | 5.1% | 3.8% | 6% |